GABRIELLA ZACCONE: Open Payments
NPI 1003307737 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 22 payments from 10 companies in 2025. Trend: 2023 $233 · 2024 $495 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $139 |
| Ardelyx, Inc. | 3 | $71 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Ipsen Biopharmaceuticals, Inc | 2 | $50 |
| Lilly USA, LLC | 2 | $48 |
| ABBVIE INC. | 2 | $35 |
| Digestive Care, Inc. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| PFIZER INC. | 1 | $16 |
Products named: XIFAXAN, IBSRELA, VOQUEZNA, IQIRVO, OMVOH, Pertzye, DUPIXENT, ENTYVIO.
Industry payments across DE — which companies pay providers there.
